Clinical Trial Update: A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rucaparib to physician's choice in metastatic castration-resistant prostate cancer with homologous recombination deficiency has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Metastatic Castration Resistant Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-08-16